TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Cytomx Therapeutics
CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

CytomX Therapeutics, a clinical-stage oncology-focused biopharmaceutical company, announced upcoming presentations of its clinical-stage pipeline including CX-2051 and CX-801, with Phase 1 data updates expected in early 2026.

Insights
CTMX   positive

Company is progressing clinical trials, presenting new data, and has strategic collaborations with major pharmaceutical companies